香豆素联合传染性造血器官坏死病毒灭活疫苗对虹鳟的免疫效果

IMMUNE EFFECTS OF COUMARIN COMBINED WITH INACTIVATED INFECTIOUS HEMATOPOIETIC NECROSIS VIRUS VACCINE ON RAINBOW TROUT (ONCORHYNCHUS MYKISS)

  • 摘要: 开发安全有效的疫苗是预防虹鳟传染性造血器官坏死病毒(IHNV)爆发的关键。本研究重点开发了以香豆素为佐剂的IHNV灭活疫苗, 疫苗安全性实验证明IHNV病毒液已被完全灭活。实验分为对照组、疫苗组和香豆素+疫苗组。疫苗注射剂量为150 μL, 对照组注射同等剂量的磷酸盐缓冲溶液(PBS), 在疫苗接种14d (D14)后进行IHNV攻毒实验, 并在D7、D14、D15、D21、D30进行虹鳟脾脏和血清的样本采集。IHNV攻毒后显示, 香豆素+疫苗的存活率为66%, 而单一灭活疫苗和对照组的分别为62%和24%。组织病理学分析显示, IHNV攻毒后香豆素+疫苗组脾脏组织损伤最小, 出现轻微的炎症反应, 而对照组出现严重的黑色素巨噬细胞中心(MMC)和组织炎症(TI)。此外, 在D7—D30, 香豆素+疫苗组血清的总超氧化物歧化酶(T-SOD)、过氧化氢酶(CAT)、碱性磷酸酶(AKP)、酸性磷酸酶(ACP)活性水平显著高于疫苗组和对照组(P<0.05)。在D7—D14, 香豆素+疫苗组血清中谷丙转氨酶(GPT)、谷草转氨酶(GOT)水平被显著升高; 而IHNV攻毒后(D15—D30), 香豆素+疫苗组GPT和GOT水平显著低于对照组(P<0.05)。在接种疫苗和攻毒后, 香豆素+疫苗组中脾脏的MHC-IMHC-IIIFN-γ基因被显著上调(P<0.05); 同时, 香豆素+疫苗组CD4CD8IgT、C3VIG1Mx1基因表达量显著高于疫苗组和对照组(P<0.05)。结果表明, 灭活疫苗联合佐剂香豆素是预防IHNV感染的有效方法, 有助于进一步控制虹鳟养殖中的IHNV暴发。

     

    Abstract: Infectious hematopoietic necrosis virus (IHNV) is one of the pathogens responsible for massive mortality in juvenile rainbow trout. Vaccines can induce immune response in the body, which leads to the production of appropriate antibodies that help protect against pathogen invasion. Therefore, the development of a safe and effective vaccine is the key for preventing IHNV outbreaks. Vaccine safety experiments revealed no clinical signs of IHN or mortality in rainbow trout, proving that the IHNV viral fluid was completely inactivated. The experiment was divided into control, vaccine, and coumarin+vaccine groups. The vaccine was injected in a dose of 150 μL, and the control group was injected with the same dose of phosphate buffer solution (PBS). The IHNV attack experiments were performed 14d post-vaccination (D14), and samples of rainbow trout spleen and serum were taken at D7, D14, D15, D21, and D30. The IHNV attack showed a survival rate of 66% in the coumarin+vaccine group compared to 62% in the inactivated vaccine group and 24% in the control group. Histopathological analysis showed minimal splenic tissue damage and mild inflammatory reaction in the coumarin+vaccine group after IHNV tapping, whereas the control group showed severe melanin macrophage center (MMC) and tissue inflammation (TI). In addition, at D7—D30, the serum levels of total superoxide dismutase (T-SOD), catalase (CAT), alkaline phosphatase (AKP), and acid phosphatase (ACP) activities in the coumarin+vaccine group were significantly higher than those in the vaccine and control groups (P<0.05). At D7—D14, the serum levels of ghrelin transaminase (GPT) and ghrelin oxaloacetate transaminase (GOT) were significantly elevated in the coumarin+vaccine group, while after IHNV attack (D15—D30), the levels of GPT and GOT in coumarin+vaccine group were significantly lower than those in the control group (P<0.05). Gene expression analysis showed a significant upregulation of MHC-I, MHC-II, and IFN-γ in the spleen in the coumarin+vaccine group after vaccination and IHNV challenge (P<0.05). Meanwhile, the expression of CD4, CD8, IgT, C3, VIG1, and Mx1 genes was significantly higher in the coumarin+vaccine group than that in the vaccine and control groups (P<0.05). These results suggest that an inactivated vaccine combined with the adjuvant coumarin is an effective method for preventing IHNV infections, which may help to further control IHNV outbreaks in rainbow trout farming.

     

/

返回文章
返回